Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction
Blood Journal · 2023
DOI: 10.1182/blood.2023020100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Journal, 2023. Verfasst von Mehmet Emrah Selli und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Section of Cellular Therapies, Washington University School of Medicine, St. Louis, MO. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Lymphoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
T cells engineered to express chimeric antigen receptors (CARs) targeting CD19 have demonstrated impressive activity against relapsed or refractory B cell cancers yet fail to induce durable remissions for nearly half of patients treated. Enhancing the efficacy of this therapy requires detailed understanding of the molecular circuitry that restrains CAR-driven anti-tumor T cell function. We developed and validated an in vitro model that drives T cell dysfunction through chronic CAR activation and interrogated how CAR costimulatory domains, central components of CAR structure and function, contribute to T cell failure. We found that chronic activation of CD28-based CARs results in activation of classical T cell exhaustion programs and development of dysfunctional cells that bear the hallmarks of exhaustion. In contrast, 41BB-based CARs activate a divergent molecular program and direct differentiation of T cells into a novel cell state. Interrogation of CAR T cells from a patient with progressive lymphoma confirmed activation of this novel program in a failing clinical product. Further, we demonstrate that 41BB-dependent activation of the transcription factor FOXO3 is directly responsible for impairing CAR T cell function. These findings identify that costimulatory domains are critical regulators of CAR-driven T cell failure and that targeted interventions are required to overcome costimulation-dependent dysfunctional programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Section of Cellular Therapies, Washington University School of Medicine, St. Louis, MO.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
- Division of Oncology, Section of Molecular Oncology, Washington University School of Medicine, St. Louis, MO.
- Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, St. Louis, MO.
ORCID-Profile: Mehmet Emrah Selli, Marina Terekhova, John Lattin, Amanda Heard, Yu-Sung Hsu, John Warrington, Natalie Kingston, Graham Hogg, Michael Slade, Melissa M Berrien-Elliott, Agata Gruszczynska, Todd A Fehniger, Nathan Singh
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Selli, M. E., Landmann, J. H., Terekhova, M., Lattin, J., Heard, A., Hsu, Y. S., Chang, T. C., Chang, J., Warrington, J., Ha, H., Kingston, N., Hogg, G., Slade, M., Berrien-Elliott, M. M., Foster, M., Kersting-Schadek, S., Gruszczynska, A., DeNardo, D., Fehniger, T. A., …, & Singh, N. (2023). Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction. Blood Journal. https://doi.org/10.1182/blood.2023020100
Vancouver
Selli ME, Landmann JH, Terekhova M, Lattin J, Heard A, Hsu YS, et al. Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction. Blood Journal. 2023. doi:10.1182/blood.2023020100
BibTeX
@article{Selli2023,
author = {Selli, Mehmet Emrah and Landmann, Jack H and Terekhova, Marina and Lattin, John and Heard, Amanda and Hsu, Yu-Sung and Chang, Tien-Ching and Chang, Jufang and Warrington, John and Ha, Helen and Kingston, Natalie and Hogg, Graham and Slade, Michael and Berrien-Elliott, Melissa M and Foster, Mark and Kersting-Schadek, Samantha and Gruszczynska, Agata and DeNardo, David and Fehniger, Todd A and Artyomov, Maxim and Singh, Nathan},
title = {Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction},
journal = {Blood Journal},
year = {2023},
doi = {10.1182/blood.2023020100}
}
EUVIMED